OPEN-SOURCE SCRIPT

WEN_GPT - CDC Action Zone V.2

148
**WEN_GPT - CDC Action Zone V.2 Strategy**

The **WEN_GPT - CDC Action Zone V.2 Strategy** is a trend-following strategy based on the **CDC Action Zone** indicator, which utilizes two exponential moving averages (EMAs) to identify bullish and bearish trends. This strategy is designed for medium-volatility markets and executes trades based on trend reversals.

**Key Features:**
- **EMA-Based Trend Detection:**
- A short EMA (Fast) and a long EMA (Slow) are calculated using an additional smoothing EMA (AP).
- A bullish trend is identified when the Fast EMA crosses above the Slow EMA.
- A bearish trend is identified when the Fast EMA crosses below the Slow EMA.

- **Trade Execution Logic:**
- **Long Entry:** Opens a long position when the trend shifts from bearish to bullish.
- **Exit Position:** Closes the long position when the trend shifts from bullish to bearish.
- **No Short Trades:** This strategy only takes long positions and exits instead of opening short trades.

- **Visual Elements for Market Analysis:**
- Plots the Fast and Slow EMAs on the chart.
- Uses dynamic bar coloring to represent different market conditions:
- **Green:** Strong bullish momentum.
- **Red:** Strong bearish momentum.
- **Yellow:** Weak bullish signal (caution).
- **Blue:** Weak bearish signal (caution).

- **Risk Management & Execution Settings:**
- Uses 100% of the account equity for each trade.
- Includes a **0.1% commission** and **3-point slippage** to simulate real trading conditions.
- Trades are only executed within the user-defined time range (default: **January 1, 2018 – December 31, 2030**).

This strategy is ideal for traders looking for **trend-following** setups with clear entry and exit signals. It provides a structured approach to capitalizing on trend shifts while maintaining an intuitive visual representation of market conditions.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.